New Monoclonal Antibodies Adding Power to CLL Treatment

patientpower has 2408 videos Subscribe Here

Description: The monoclonal antibody, Rituximab, has been a backbone of CLL treatment for several years. It targets a protein on the CLL cells. Now a more powerful antibody may be available soon and has shown promising results in clinical trials. While attending a gathering of world CLL experts in Cologne, Germany Dr. Thomas Kipps from UC San Diego sat down with Patient Power's Andrew Schorr to explain the role of antibodies in CLL treatment and his optimism about new combination therapies to help people live longer and better.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 09/17/13
Added : 4 years ago
Category : General